Host factors in dimorphic fungal infections

Host factors in dimorphic fungal infections

Host factors in dimorphic fungal infections

On this page

Innate Immunity - The Body's First Stand

  • Physical & Chemical Barriers: Intact skin and mucous membranes are the first line. Low pH, fatty acids on the skin, and cilia in the respiratory tract prevent fungal settlement.
  • Key Cellular Players:
    • Macrophages (especially Alveolar): Engulf inhaled spores/conidia. Recognize fungal PAMPs (e.g., β-glucan, chitin) via Pattern Recognition Receptors (PRRs) like TLRs and Dectin-1.
    • Neutrophils: Rapidly recruited to sites of infection. Kill fungi via phagocytosis, degranulation (releasing antifungal peptides), and formation of Neutrophil Extracellular Traps (NETs).
    • Natural Killer (NK) Cells: Provide early defense by directly killing fungal cells and secreting cytokines like IFN-γ to potentiate macrophage activity.

Exam Favorite: Histoplasma capsulatum famously survives and replicates within the phagolysosome of inactivated macrophages, using this as a "Trojan horse" to disseminate systemically.

Immune cell PRRs and signaling in fungal infections

Adaptive Immunity - T-Cell Titans Take Charge

  • Cell-Mediated Immunity (CMI) is Paramount: The host's primary defense against dimorphic fungi relies on a robust T-cell response, not antibodies.
  • Key Player: CD4+ Th1 cells orchestrate the entire defense.
    • Mechanism: Upon recognizing fungal antigens, Th1 cells release Interferon-gamma (IFN-γ).
    • Action: IFN-γ super-activates macrophages, boosting their ability to kill the intracellular yeast forms.
  • Clinical Significance of Immunodeficiency:
    • Conditions with ↓ T-cell function (e.g., AIDS with CD4 < 200 cells/μL, lymphoma, TNF-α inhibitors) cripple this defense.
    • Leads to uncontrolled fungal replication and severe, disseminated disease.

High-Yield: Patients on TNF-α inhibitors (e.g., infliximab) are at high risk for reactivating latent histoplasmosis. TNF-α is critical for forming and maintaining the granulomas that contain the fungi.

Macrophage polarization in fungal infections

Immunodeficiency - When Defenses Crumble

  • Cell-Mediated Immunity (CMI) is Paramount: T-cell (especially CD4+ helper T-cells) and macrophage function are critical for containing dimorphic fungi in their yeast form within granulomas.

    • Failure leads to: Disseminated, life-threatening disease instead of localized, asymptomatic infection.
  • Key Immunocompromised States & Associated Risks:

    • HIV/AIDS: Risk of dissemination ↑ significantly with CD4+ count < 150 cells/μL. Common with Histoplasma and Coccidioides.
    • Pharmacologic Immunosuppression:
      • TNF-α inhibitors (e.g., infliximab, etanercept): Impair granuloma formation and maintenance.
      • High-dose corticosteroids & Calcineurin inhibitors: Broadly suppress T-cell activation.
    • Primary Immunodeficiencies:
      • Chronic Granulomatous Disease (CGD): Defective NADPH oxidase impairs phagocyte killing of fungi.

Host factors in dimorphic fungal infections

TNF-α is essential for maintaining granulomas that contain latent Histoplasma capsulatum. Starting a TNF-α inhibitor can lead to reactivation and severe, disseminated histoplasmosis, often mimicking miliary tuberculosis.

High‑Yield Points - ⚡ Biggest Takeaways

  • Cell-mediated immunity, driven by Th1-lymphocytes, is the primary host defense against dimorphic fungi.
  • Immunocompromised hosts, especially those with impaired T-cell function (e.g., AIDS, lymphoma), are highly susceptible to disseminated disease.
  • Use of TNF-alpha inhibitors is a major risk factor for reactivation of latent infections like Histoplasmosis.
  • The thermal dimorphism (mold-to-yeast transition) is a key virulence factor that helps evade host defenses.
  • Most infections in immunocompetent individuals are asymptomatic or self-limiting, conferring future immunity.

Practice Questions: Host factors in dimorphic fungal infections

Test your understanding with these related questions

A 26-year-old man comes to the physician for a follow-up examination. He was diagnosed with HIV infection 2 weeks ago. His CD4+ T-lymphocyte count is 162/mm3 (N ≥ 500). An interferon-gamma release assay is negative. Prophylactic treatment against which of the following pathogens is most appropriate at this time?

1 of 5

Flashcards: Host factors in dimorphic fungal infections

1/10

Transmission of paracoccidioidomycosis occurs via _____

TAP TO REVEAL ANSWER

Transmission of paracoccidioidomycosis occurs via _____

respiratory droplets

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial